Welcome to KBC Securities

We believe banking is a craft, not an art or a science. As the integrated Equity House of KBC Group, we combine specialist expertise, skill and personal commitment to bring lasting value to our clients and people.

More about us


Our services

Collapse research area

Latest research

Benelux Morning Note26 jun 2017

Ablynx: First dosing of Caplacizumab in Japanese subjects Corbion: Preferred shares converted into ordinary shares Mithra: Publication on Estelle PhIIb body weight results Proximus: “Much more” data for “more” pricing Tel ...

Benelux Morning Note23 jun 2017

Colruyt: Adjusting our numbers Corbion: Takeover rumours push share price up over 11% Nyrstar: Glencore to provide support for Port Pirie Tigenix: Presenting at the 7th TERMIS-EU Industry Day

Benelux Morning Note22 jun 2017

Bekaert: Sumare deal closed: impact more limited than exp. CFE: Lower Offshore wind subsidies for Belgium Cofinimmo: Feedback CMD in Brussels Proximus: Scarlet launches “HiFive”, € 15 for 5 Gb Recticel: Plans investment i ...

Benelux Morning Note21 jun 2017

AB InBev: Rumour about divestment of Hasseroeder/Diebels Colruyt: Increasing competitive pressure hurts 2H margins Galapagos: Pipeline update R&D conference NY Gimv: Sold Greenyard stake Greenyard: Free float further incr ...

Benelux Morning Note20 jun 2017

Argenx: Progress in LEO Pharma partnership ASIT biotech: TP decrease due to gp-ASIT+ Ph3 repetition Celyad: TP/rating increase following first + signs in THINK Cofinimmo: € 12.6m senior home acquisition in Germany Galapag ...

Benelux Morning Note19 jun 2017

Ageas: Fortis settlement not declared binding Ahold Delhaize: The wild wild west ASIT biotech: Phase III results – Regulatory feedback Celyad: Promising early results of the THINK trial Colruyt: Preview FY16/17

Benelux Morning Note16 jun 2017

Greenyard: Adjusting the model after Mykogen Thrombogenics: Thomas Clay appointed as chairman of the board

Benelux Morning Note15 jun 2017

ForFarmers: Time for a breather Greenyard: “Mush room” for upside Tigenix: Partnering US/EU advocacy groups for CD and UC